Home›Legal›NAD+ in California
NAD+ in California: Legal Status & Provider Guide (2026)
Quick Answer
NAD+ is a prescription substance in the United States. NAD+ in injectable form can be lawfully compounded by 503A pharmacies under a valid prescription. Oral NAD+ precursors (NR, NMN) are available as dietary supplements without a prescription. Injectable NAD+ protocols require physician oversight and pharmacy compounding. In California, compounding is governed by the California State Board of Pharmacy (CSBP). California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
Federal Legal Status
FDA Approval Status
NAD+ is not FDA-approved as a prescription drug. It is generally recognized as a nutritional supplement precursor (via NR and NMN) when taken orally. Injectable NAD+ has been compounded by licensed pharmacies and is considered legally permissible under current FDA guidance in IV/injection form when prescribed.
Compounding Pharmacy Rules (Federal)
Injectable NAD+ (nicotinamide adenine dinucleotide) can be compounded by licensed 503A pharmacies under a valid prescription. It is not on the 503B bulk substances list but has historically been offered by many compounding pharmacies for IV infusion or subcutaneous injection under physician oversight. Its regulatory status is more permissive than most synthetic peptides.
Also Known As
Nicotinamide Adenine Dinucleotide · NAD · β-NAD+
Primary Research Areas
- Cellular energy
- Anti-aging
- Neurological support
- Addiction recovery support
- Metabolic health
California Pharmacy Board & Compounding Rules
Compounding Overview
The California State Board of Pharmacy enforces strict compounding standards, often exceeding federal minimums. California has its own sterile compounding licensure category and requires all sterile compounding pharmacies to hold a specialty license. California pharmacies must comply with USP 797 (sterile) and USP 795 (non-sterile) standards. The California Medical Board also imposes strict telemedicine prescribing standards that affect peptide clinics operating as telehealth platforms serving California residents.
Notable Rules
- California requires a specialty sterile compounding license in addition to a standard pharmacy license.
- USP 797 and 795 compliance is mandatory for all California-licensed compounding pharmacies.
- The California Medical Board has specific guidance on prescribing practices for "off-label" and compounded medications.
- Out-of-state pharmacies must be licensed by CSBP to ship prescription compounds into California.
- California prohibits prescription dispensing without an established patient-provider relationship in most telehealth contexts.
Prescribing Requirements in California
California allows nurse practitioners and physician assistants with standardized procedures or physician collaboration to prescribe compounded peptides. California's telehealth laws (AB 2019 and subsequent legislation) require an established patient-provider relationship before prescribing. Out-of-state prescribers cannot prescribe to California patients without a California license.
About NAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in all living cells, central to energy metabolism and DNA repair. Research interest has expanded significantly with studies linking NAD+ decline to aging. Clinical research focuses on replenishment via IV infusion or oral precursors.
For more research information, mechanism of action, and provider availability, see the NAD+ research profile on PeptideBase.
Frequently Asked Questions
- Is injectable NAD+ legal?
- Injectable NAD+ can be legally compounded by licensed 503A compounding pharmacies under a valid physician prescription. It is not FDA-approved as a drug but has a permissive compounding status compared to many synthetic peptides.
- What is the difference between oral NAD+ supplements and IV NAD+?
- Oral supplements typically deliver NAD+ precursors (NR or NMN) which the body converts. IV NAD+ delivers the coenzyme directly into the bloodstream, which proponents claim produces faster and more pronounced effects, though comparative clinical data is limited.
NAD+ Providers in California
No providers currently listed in California for NAD+. Browse the full directory to find providers offering NAD+.
Browse all NAD+ providers →NAD+ Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare NAD+ legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .